Cheng-Mayer C - Search Results

1

The use of nonhuman primate models in HIV vaccine development.

Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, Self S, Corey L. Morgan C, et al. PLoS Med. 2008 Aug 12;5(8):e173. doi: 10.1371/journal.pmed.0050173. PLoS Med. 2008. PMID: 18700814 Free PMC article.

2

HIV-1 variation: consequences for disease progression and vaccine strategies.

Cheng-Mayer C. Cheng-Mayer C. Trends Microbiol. 1993 Dec;1(9):353-5. doi: 10.1016/0966-842x(93)90077-5. Trends Microbiol. 1993. PMID: 8162426

3

Developments in preclinical AIDS vaccine efficacy models.

Bogers WM, Cheng-Mayer C, Montelaro RC. Bogers WM, et al. AIDS. 2000;14 Suppl 3:S141-51. AIDS. 2000. PMID: 11086857 Review. No abstract available.

4

Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance.

Boyd DF, Sharma A, Humes D, Cheng-Mayer C, Overbaugh J. Boyd DF, et al. Among authors: cheng mayer c. PLoS Pathog. 2016 Jul 11;12(7):e1005727. doi: 10.1371/journal.ppat.1005727. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27399306 Free PMC article.

5

Biologic features of HIV-1 that correlate with virulence in the host.

Cheng-Mayer C, Seto D, Tateno M, Levy JA. Cheng-Mayer C, et al. Science. 1988 Apr 1;240(4848):80-2. doi: 10.1126/science.2832945. Science. 1988. PMID: 2832945

6

Human immunodeficiency virus infection of the CNS: characterization of "neurotropic" strains.

Cheng-Mayer C, Levy JA. Cheng-Mayer C, et al. Curr Top Microbiol Immunol. 1990;160:145-56. doi: 10.1007/978-3-642-75267-4_9. Curr Top Microbiol Immunol. 1990. PMID: 2191840 Review. No abstract available.

7

Differential effects of nef on HIV replication: implications for viral pathogenesis in the host.

Cheng-Mayer C, Iannello P, Shaw K, Luciw PA, Levy JA. Cheng-Mayer C, et al. Science. 1989 Dec 22;246(4937):1629-32. doi: 10.1126/science.2531920. Science. 1989. PMID: 2531920

8

HIV heterogeneity and viral pathogenesis.

Castro BA, Cheng-Mayer C, Evans LA, Levy JA. Castro BA, et al. AIDS. 1988;2 Suppl 1:S17-27. doi: 10.1097/00002030-198800001-00004. AIDS. 1988. PMID: 3147667 Review.

9

Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.

Koito A, Harrowe G, Levy JA, Cheng-Mayer C. Koito A, et al. J Virol. 1994 Apr;68(4):2253-9. doi: 10.1128/JVI.68.4.2253-2259.1994. J Virol. 1994. PMID: 8139010 Free PMC article.

10

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.

Shioda T, Levy JA, Cheng-Mayer C. Shioda T, et al. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9434-8. doi: 10.1073/pnas.89.20.9434. Proc Natl Acad Sci U S A. 1992. PMID: 1409653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters